ArticleFrontiers in bioinformatics2026
Beyond presence and frequency: a determinant-level framework for interpreting AMR dissemination in One Health surveillance.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genomic sequencing is now routine in One Health antimicrobial resistance (AMR) surveillance, but reports often stop at presence and frequency and do not distinguish a determinant confined to one genomic background from one recurring across lineages, reservoirs, and reporting periods-patterns that warrant different action. We propose the Determinant Dissemination State (Dg-state), a determinant-level interpretation layer that classifies each resistance determinant as Contained, Emerging, Disseminating, or Abstain. We specify the complete decision rule under a single notation: six bounded evidentiary domains; a composite dissemination score with default weights; an uncertainty-adjusted score that discounts weak genomic context and thin sampling; an explicit sampling-adequacy gate; a two-stage classification separating confined recurrence from genuine cross-reservoir or cross-lineage spread; and a classification-stability measure. As a proof-of-concept, and with an accompanying reference implementation, we apply the framework to a literature-anchored simulated surveillance dataset with known ground truth, where it reproduces the intended labels and behaves robustly. Dg-state does not infer transmission; it provides an auditable, reproducible way to prioritise determinants for escalation, targeted resampling, and higher-resolution genomic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.